Financials
Financial year 2026
Dr. Kristel De Keyzer, nefrologe from Zonnebeke, company number BE0507754022, closed financial year 2026 with a result of € 504,795 after tax. For that financial year Dr. Kristel De Keyzer, nefrologe recorded a gross margin of € 713,458 and equity of € 2 million. Compared with financial year 2025, the result moved from € 490,987 to € 504,795. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 20, 2026.
€ 2 million
▲ 18% vs 2025
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 504,795
▲ 3% vs 2025
Profit after tax over the fiscal year.
€ 230,811
▼ 50% vs 2025
Cash and bank balances on the last day of the fiscal year.
€ 195,545 paid out
39 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2026
€ 1,290
▼ 82% vs 2025
Book value of vehicles, furniture and equipment.
Debts at end 2026
None
No bank loans on the last day of the fiscal year.
€ 55,040
▲ 10% vs 2025
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2023 | 2024 | 2025 | 2026 | Change 2025 → 2026 | |
|---|---|---|---|---|---|
| Gross margin | € 443,943 | € 498,820 | € 696,296 | € 713,458 | ▲ 2% |
| Profit after taxes | € 285,192 | € 321,869 | € 490,987 | € 504,795 | ▲ 3% |
| Equity | € 1,089,920 | € 1,338,865 | € 1,736,331 | € 2,045,581 | ▲ 18% |
| Total debts | € 77,098 | € 55,536 | € 53,804 | € 56,392 | ▲ 5% |
| Cash | € 672,731 | € 326,337 | € 466,216 | € 230,811 | ▼ 50% |
| Retained profit | € 1,071,320 | € 1,320,265 | € 1,717,731 | € 2,026,981 | ▲ 18% |
| Dividend | € 1,600 | € 72,924 | € 93,521 | € 195,545 | ▲ 109% |
| Bank debt | € 39,545 | € 20,703 | € 1,603 | € 0 | ▼ 100% |
| Balance sheet total | € 1,167,018 | € 1,394,401 | € 1,790,135 | € 2,101,973 | ▲ 17% |
Key figures of Dr. Kristel De Keyzer, nefrologe, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.
What happened to Dr. Kristel De Keyzer, nefrologe?
What happened at Dr. Kristel De Keyzer, nefrologe in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2026: profit of € 504,795 (▲ 3% vs 2025). Source: NBB ↗
- New establishment in Merelbeke-Melle. KBO
- Kristel De Keyzer became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 285,192 profit in 2023 to € 504,795 profit in 2026.
Paid € 716,423 in corporate taxes since 2023.
Best year ever: 2026, with € 504,795 profit.
Paid out € 363,590 in dividends to the owners in total.
Management
Behind Dr. Kristel De Keyzer, nefrologe is Kristel De Keyzer. Kristel De Keyzer is also behind NEFROLOGIE IEPER.
Directors
According to the 2026 annual accounts
since 2014
Establishments
Establishment units
Physical locations of this company
Waterstraat 17
8980 Zonnebeke
Burg. Van Cauwenberghestraat 41
9820 Merelbeke-Melle
Active since 1 January 2015
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0507.754.022
- VAT number
- BE 0507.754.022
- Registered office
- Waterstraat 17, 8980 Zonnebeke
- Names & denominations
- Dr. Kristel De Keyzer, nefrologe
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 24 December 2014
- Peppol
- Active · Active since 21 Oct 2026
- Activities · NACE
Activiteiten van medisch specialisten
Activiteiten op het gebied van voeding
Overige menselijke gezondheidszorg, n.e.g.